John Hancock Capital Series Classic Value Fund Class R5 (JCVVX)
| Fund Assets | 513.34M |
| Expense Ratio | 0.84% |
| Min. Investment | $1,000 |
| Turnover | 13.00% |
| Dividend (ttm) | 7.09 |
| Dividend Yield | 38.94% |
| Dividend Growth | -43.24% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 19, 2025 |
| Previous Close | 18.46 |
| YTD Return | -6.76% |
| 1-Year Return | 4.36% |
| 5-Year Return | 15.20% |
| 52-Week Low | 18.09 |
| 52-Week High | 26.86 |
| Beta (5Y) | n/a |
| Holdings | 35 |
| Inception Date | May 22, 2009 |
About JCVVX
The John Hancock Classic Value Fund Class R5 is a mutual fund designed to achieve long-term capital growth by focusing primarily on undervalued large-cap U.S. companies. The fund typically invests at least 80% of its net assets in domestic equity securities, selecting stocks that management believes are trading below their intrinsic value based on forward-looking measures such as estimated future earnings and cash flow. Companies targeted for the portfolio often present lower price-to-book ratios compared to the broader market, particularly the S&P 500 Index, embodying a classic value investment approach. Up to 20% of assets may be allocated to foreign securities, expanding diversification beyond U.S. borders. The fund’s structure and share class are tailored for use in certain employer-sponsored retirement plans, offering daily liquidity and professional asset management. With a significant asset base and a disciplined value-oriented strategy, the John Hancock Classic Value Fund Class R5 serves as a core holding for investors seeking exposure to established U.S. firms with potential for price appreciation through market revaluation.
Performance
JCVVX had a total return of 4.36% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.63%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FVLCX | Fidelity | Fidelity Advisor Value Leaders Fund | 1.90% |
| FSLVX | Fidelity | Fidelity Stock Selector Large Cap Value Fund | 0.83% |
| SWLVX | Schwab | Schwab U.S. Large-Cap Value Index Fund | 0.03% |
| FVLIX | Fidelity | Fidelity Advisor Value Leaders Fund | 0.90% |
| FSCZX | Fidelity | Fidelity Advisor Stock Selector Large Cap Value Fund - Class Z | 0.72% |
Top 10 Holdings
43.75% of assets| Name | Symbol | Weight |
|---|---|---|
| Baxter International Inc. | BAX | 5.13% |
| CVS Health Corporation | CVS | 5.07% |
| Humana Inc. | HUM | 5.05% |
| Citigroup Inc. | C | 4.76% |
| Wells Fargo & Company | WFC | 4.22% |
| Capital One Financial Corporation | COF | 4.18% |
| Fresenius Medical Care AG | FMS | 4.07% |
| Dollar General Corporation | DG | 3.97% |
| Magna International Inc. | MG | 3.82% |
| MetLife, Inc. | MET | 3.48% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 19, 2025 | $7.08789 | Dec 22, 2025 |
| Dec 20, 2024 | $12.48777 | Dec 23, 2024 |
| Dec 19, 2023 | $2.29504 | Dec 20, 2023 |
| Dec 19, 2022 | $6.10452 | Dec 20, 2022 |
| Dec 17, 2021 | $0.35429 | Dec 20, 2021 |
| Dec 18, 2020 | $0.47914 | Dec 21, 2020 |